Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MDM Strategies is a healthcare consulting and technology firm that provides strategic market access, reimbursement, and risk adjustment solutions to the pharmaceutical, biotechnology, and healthcare payer industries. The company specializes in navigating the complexities of Medicare Advantage, Medicaid, and Commercial insurance markets, offering services such as clinical coding, HEDIS analytics, and medical record retrieval. In 2018, its risk adjustment business was acquired by Episource, a leading provider of quality and risk adjustment solutions, to enhance its technology-enabled services. MDM Strategies continues to offer specialized consulting to help life science companies optimize commercialization strategies and patient access to therapies. The firm leverages deep expertise in healthcare policy and data analytics to assist clients in improving financial performance and clinical outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mdm Strategies.